Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.35 BRL | +4.44% | -4.08% | -12.96% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 9.74 | 15.13 | 122.1 | 72.37 | 32.69 | 13.68 |
Enterprise Value (EV) 1 | 202.1 | 222.5 | 357.7 | 354.3 | 348.7 | 310.4 |
P/E ratio | -0.66 x | 0.71 x | -2.33 x | -1.59 x | 12.3 x | 0.69 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.11 x | 0.14 x | 1.46 x | 0.45 x | 0.15 x | 0.1 x |
EV / Revenue | 2.31 x | 2.12 x | 4.28 x | 2.19 x | 1.64 x | 2.34 x |
EV / EBITDA | 14.7 x | 16.4 x | 41.5 x | 9.88 x | 10.8 x | 6.2 x |
EV / FCF | -84.1 x | -5.79 x | -22.5 x | -10.3 x | -11.5 x | 66.9 x |
FCF Yield | -1.19% | -17.3% | -4.45% | -9.73% | -8.66% | 1.49% |
Price to Book | -0.02 x | -0.05 x | -0.13 x | -0.1 x | -0.04 x | -0.04 x |
Nbr of stocks (in thousands) | 4,259 | 4,259 | 4,259 | 4,259 | 4,259 | 4,259 |
Reference price 2 | 1.760 | 3.590 | 9.780 | 8.150 | 3.240 | 2.700 |
Announcement Date | 3/28/19 | 3/31/20 | 3/26/21 | 3/25/22 | 3/24/23 | 3/28/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 87.33 | 105.1 | 83.54 | 162.1 | 212.4 | 132.7 |
EBITDA 1 | 13.77 | 13.53 | 8.61 | 35.86 | 32.37 | 50.08 |
EBIT 1 | 8.537 | 8.613 | 3.758 | 30.93 | 32.02 | 47.49 |
Operating Margin | 9.78% | 8.2% | 4.5% | 19.08% | 15.07% | 35.79% |
Earnings before Tax (EBT) 1 | -11.3 | 21.48 | -17.85 | -21.74 | 1.168 | 16.79 |
Net income 1 | -11.44 | 21.41 | -17.9 | -21.79 | 1.123 | 16.74 |
Net margin | -13.1% | 20.38% | -21.43% | -13.44% | 0.53% | 12.62% |
EPS 2 | -2.687 | 5.027 | -4.204 | -5.116 | 0.2637 | 3.932 |
Free Cash Flow 1 | -2.402 | -38.43 | -15.92 | -34.47 | -30.21 | 4.636 |
FCF margin | -2.75% | -36.57% | -19.06% | -21.27% | -14.22% | 3.49% |
FCF Conversion (EBITDA) | - | - | - | - | - | 9.26% |
FCF Conversion (Net income) | - | - | - | - | - | 27.69% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/28/19 | 3/31/20 | 3/26/21 | 3/25/22 | 3/24/23 | 3/28/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 192 | 207 | 236 | 282 | 316 | 297 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 13.97 x | 15.32 x | 27.36 x | 7.863 x | 9.761 x | 5.924 x |
Free Cash Flow 1 | -2.4 | -38.4 | -15.9 | -34.5 | -30.2 | 4.64 |
ROE (net income / shareholders' equity) | 3.71% | -7.09% | 5.96% | 6.79% | -0.34% | -5.19% |
ROA (Net income/ Total Assets) | 3.02% | 2.99% | 1.25% | 9.62% | 8.68% | 13.3% |
Assets 1 | -378.8 | 714.9 | -1,433 | -226.5 | 12.94 | 126.2 |
Book Value Per Share 2 | -73.40 | -68.40 | -72.70 | -77.90 | -77.70 | -73.70 |
Cash Flow per Share 2 | 0.2000 | 0.0900 | 0.0400 | 0.0600 | 0.0400 | 0.1000 |
Capex | - | 5.47 | - | - | - | 0.18 |
Capex / Sales | - | 5.21% | - | - | - | 0.14% |
Announcement Date | 3/28/19 | 3/31/20 | 3/26/21 | 3/25/22 | 3/24/23 | 3/28/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-12.96% | 3.82M | |
-15.90% | 352M | |
+18.52% | 290M | |
-54.27% | 237M | |
+113.68% | 121M | |
+99.02% | 103M | |
-6.30% | 94.02M | |
-32.03% | 89.87M | |
+37.90% | 86.25M | |
+3.03% | 74.9M |
- Stock Market
- Equities
- TXRX4 Stock
- Financials Têxtil Renauxview S.A.